Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Medigrape Advise AB
AB
Active
Org 5567713358
Lilla Vägen 12, 235 91
Vellinge
Medical specialists activities
·
NACE 8622
Est. 2008 · 17 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Medigrape Advise AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 2M (-33% vs 2022)
2M
-33%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 1M
1M
2025
EBITDA
SEK millions
2M
1M
0M
-1M
-2M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: -1M (-200% vs 2023)
-1M
-200%
2024
2025: 0M (+100% vs 2024)
0M
+100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
633
401
2 126
2 755
2 638
Staff expenses
—
—
—
—
—
EBITDA
−99
−1 057
537
1 129
989
Depreciation & amort.
−101
−107
−107
−60
−3
EBIT
−200
−1 164
430
1 069
986
Net financials
3
−8
−32
211
—
Profit before tax
−18
−83
464
1 081
957
Tax
−0
−0
−108
−182
−210
Net profit
−18
−83
356
899
747
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
910
1 374
3 303
3 647
3 010
Equity
100
707
1 290
1 434
1 035
Long-term debt
0
0
0
0
0
Short-term debt
442
119
391
544
529
Total debt
442
119
391
544
529
Financial ratios
5-year trend
EBITDA margin
−15,6 %
This company
15,8 %
Market median
This company
Market median
199% below market
2021
2025
Equity ratio
11,0 %
This company
38,2 %
Market median
This company
Market median
71% below market
2021
2025
Return on equity
−18,0 %
This company
18,4 %
Market median
This company
Market median
198% below market
2021
2025
Net profit margin
−2,8 %
This company
8,1 %
Market median
This company
Market median
135% below market
2021
2025
Asset turnover
0,70×
This company
1,12×
Market median
This company
Market median
38% below market
2021
2025
Debt / equity
8,10×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Medigrape Advise AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
